Abstract
Minocycline is broadly protective in neurologic disease models featuring cell death and is being evaluated in clinical trials. Whether it also protects non-neuronal cells or tissues is not known. The...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
